Lucid Diagnostics (LUCD) Net Income Growth (3y) (2023 - 2026)
Lucid Diagnostics (LUCD) Net Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 280.49% |
| 10 | Lucid Diagnostics | 126.63 Mn | 98.76 Mn | -325,000.00 | 5.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.05% |
| Dec 31, 2025 | -2.90% |
| Sep 30, 2025 | 10.18% |
| Jun 30, 2025 | 32.79% |
| Mar 31, 2025 | -29.92% |
| Dec 31, 2024 | -0.69% |
| Sep 30, 2024 | -21.15% |
| Jun 30, 2024 | -21.32% |
| Mar 31, 2024 | -42.69% |
| Dec 31, 2023 | -58.28% |
| Sep 30, 2023 | -91.55% |